THE ROLE OF MUSCARINIC M1 AND M2 RECEPTORS IN AIRWAY CONSTRICTION IN THE CAT

被引:5
|
作者
KILLINGSWORTH, CR [1 ]
ROBINSON, NE [1 ]
机构
[1] MICHIGAN STATE UNIV,DEPT LARGE ANIM CLIN SCI,PULM LAB,E LANSING,MI 48824
关键词
MUSCARINIC RECEPTORS; PARASYMPATHETIC NERVOUS SYSTEM; LUNG RESISTANCE; GALLAMINE; PIRENZEPINE; (CAT);
D O I
10.1016/0014-2999(92)90409-W
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The role of prejunctional inhibitory and facilitatory muscarinic receptors was investigated in cats with tracheal hyperresponsiveness to vagal stimulation. Intrathoracic airway caliber (total lung resistance (R(L)) and dynamic compliance (C(dyn))) and the diameter of tracheal ring 4 were measured during vagal stimulation and local acetylcholine (ACh) injection before and after administration of the M1 receptor antagonist pirenzepine or the M2 receptor antagonist gallamine. The responses of tracheal ring 4, R(L), and C(dyn) to ACh were unaltered by gallamine or pirenzepine. Changes in R(L) and C(dyn) during vagal stimulation were enhanced by gallamine, but the magnitude of tracheal constriction was unchanged. Vagally induced tracheal constriction was decreased by pirenzepine in hyperresponsive but not in control cats. The M2 receptors limit intrathoracic airway constriction, but a functional role for M2 receptors in the cervical trachea could not be demonstrated. However, these data suggest that M1 excitatory receptors may play a role in vagally mediated tracheal hyperreactivity.
引用
收藏
页码:231 / 238
页数:8
相关论文
共 50 条
  • [21] Mapping of the prenatal and postnatal methamphetamine effects on D1-like dopamine, M1 and M2 muscarinic receptors in rat central nervous system
    Farar, Vladimir
    Valuskova, Paulina
    Sevcikova, Maria
    Myslivecek, Jaromir
    Slamberova, Romana
    BRAIN RESEARCH BULLETIN, 2018, 137 : 17 - 22
  • [22] Autoradiographic distribution of M1, M2, M3, and M4 muscarinic receptor subtypes in Alzheimer's disease
    RodriguezPuertas, R
    Pascual, J
    Vilaro, T
    Pazos, A
    SYNAPSE, 1997, 26 (04) : 341 - 350
  • [23] Muscarinic (M) receptors in coronary circulation - Gene-targeted mice define the role of M2 and M3 receptors in response to acetylcholine
    Lamping, KG
    Wess, J
    Cui, YH
    Nuno, DW
    Faraci, FM
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (07) : 1253 - 1258
  • [24] Understanding the Role of Muscarinic M1 and M4 Receptors in Neural Circuits That Modulate Negative Symptoms of Schizophrenia
    Yohn, Samantha E.
    Horan, William P.
    Brannan, Stephen K.
    Paul, Steven M.
    BIOLOGICAL PSYCHIATRY, 2024, 95 (10) : S269 - S270
  • [25] Different roles for M1 and M2 receptors within perirhinal cortex in object recognition and discrimination
    Bartko, Susan J.
    Winters, Boyer D.
    Saksida, Lisa M.
    Bussey, Timothy J.
    NEUROBIOLOGY OF LEARNING AND MEMORY, 2014, 110 : 16 - 26
  • [26] EVIDENCE FOR A PREFERENTIAL INVOLVEMENT OF M1 MUSCARINIC RECEPTORS IN REPRESENTATIONAL MEMORY
    MESSER, WS
    BOHNETT, M
    STIBBE, J
    NEUROSCIENCE LETTERS, 1990, 116 (1-2) : 184 - 189
  • [27] Contribution of M1 and M2 muscarinic receptor subtypes to convulsions in fasted mice treated with scopolamine and given food
    Bacanak, Merve Saygi
    Aydin, Banu
    Cabadak, Hulya
    Nurten, Asiye
    Goren, Mehmet Zafer
    Enginar, Nurhan
    BEHAVIOURAL BRAIN RESEARCH, 2019, 364 : 423 - 430
  • [28] Functional expression of M1, M3 and M5 muscarinic acetylcholine receptors in yeast
    Erlenbach, I
    Kostenis, E
    Schmidt, C
    Hamdan, FF
    Pausch, MH
    Wess, J
    JOURNAL OF NEUROCHEMISTRY, 2001, 77 (05) : 1327 - 1337
  • [29] ACTIVATION OF NIGRAL M1 AND M2 MUSCARINIC RECEPTORS PRODUCES OPPOSING EFFECTS ON STRIATAL 3,4-DIHYDROXYPHENYLACETIC ACID MEASURED BY INVIVO VOLTAMMETRY
    GONGORAALFARO, JL
    HERNANDEZLOPEZ, S
    MARTINEZFONG, D
    BRASSART, JL
    ACEVES, J
    BRAIN RESEARCH, 1991, 554 (1-2) : 329 - 332
  • [30] Inverse agonist activity of pirenzepine at M2 muscarinic acetylcholine receptors
    Daeffler, L
    Schmidlin, F
    Gies, JP
    Landry, Y
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 (05) : 1246 - 1252